Total liabilities
Balance – as of period end · $M
Q1 2026
165$M
All values (11)
| Period | Value ($M) | Status |
|---|---|---|
| Q2 2026 | 206 | reported |
| Q1 2026 | 165 | reported |
| Q4 2025 | 168 | reported |
| Q3 2025 | 129 | reported |
| Q2 2025 | 136 | reported |
| Q1 2025 | 80 | reported |
| Q4 2024 | 90 | reported |
| Q3 2024 | 93 | reported |
| Q2 2024 | 70 | reported |
| Q1 2024 | 56 | reported |
| Q4 2023 | None | error |
| Q1 2016 – Q3 2023 | – | missing (31 periods): No verified SEC value extracted, although the company reports this metric in other periods. |
Show reported periods only · CSV with all sources · Technical ID: total_liabilities
More metrics for Astera Labs
Income statement
Balance sheet
Revenue by segment/product/region
Sources & calculation
- Value
- $165M
- Period
- Q1 2026, ended Mar 31, 2026 · as of Mar 31, 2026 (balance as of date, not a sum)
- Source
- 10-Q, filed May 6, 2026 · 0001736297-26-000020
- Location
- us-gaap:Liabilities
- Confidence
- 1. – directly from an XBRL fact in the filing (or calculated exactly from it)
Versions
| v1 | $165M | May 6, 2026 | 10-Q 0001736297-26-000020 | reported · confidence 1. · current |